SCHEMBL5606963

SCHEMBL5606963

CCN(C(=O)c1sc(N(CC(C)C)C(=O)O)nc1C)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ATM Q13315 3/20 0.37
ALDH1A1 P00352 4/20 0.34
HPGD P15428 3/20 0.34
MAPT P10636 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
LMNA P02545 1/20 0.34
KDM4E B2RXH2 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NR1H4 Q96RI1 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607284 0.81 KMT2A (0.36) KMT2ANPC1RAB9AATMALDH1A1
SCHEMBL13584460 0.72 NPC1 (0.45) KMT2ANPC1RAB9AALDH1A1HPGD
SCHEMBL6834849 0.70 GAA (0.47) KMT2ANPC1RAB9AALDH1A1HPGD
SCHEMBL5608032 0.67 MAPT (0.48) KMT2ANPC1RAB9AALDH1A1HPGD
SCHEMBL6834770 0.66 CHRNA7 (0.49) KMT2AALDH1A1MAPTKDM4EMEN1
SCHEMBL8737715 0.60 ALDH1A1 (0.46) KMT2ANPC1RAB9AALDH1A1HPGD
SCHEMBL967673 0.60
SCHEMBL5163250 0.59 ALDH1A1 (0.50) KMT2ANPC1RAB9AATMALDH1A1
Hydrochloric Acid SCHEMBL6114380 0.59 ALDH1A1 (0.45) KMT2ANPC1RAB9AALDH1A1HPGD
SCHEMBL2339336 0.58 CA1 (0.41) KMT2AALDH1A1TDP1MEN1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758564-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER Brystol-Myers Squibb Company (US) 2007-03-07 EP disclosed
WO-2005094376-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2005-10-13 WO disclosed